Brady Cobb is the CEO of international cannabis investment company SOL Global and an attorney, lobbyist, and consultant based in South Florida. Brady has emerged as a leading voice in the budding medical cannabis industry in the United States and has been instrumental to the marketplaces transition from legal and regulatory uncertainty to sensible and long overdue federal legislative policy reforms. These will provide stability and long overdue institutional growth opportunities to the medical cannabis space. As an attorney, he focuses his practice on state and federal lobbying and policy making, the development of efficient and reasonable regulatory systems and related compliance, complex license transfer/change of ownership transactions, capital markets transactions and compliance/shareholder disclosure issues with the TSX, CSE and NASDAQ. Brady was instrumental in the legislative process to implement Florida’s medical marijuana regulatory system, and also represented Liberty Health Sciences in closing the first ever MMTC license transfer in Florida. He served as the Liberty Health Sciences (LHS:CSE) Chief Legal Officer from inception through July of 2018 when he accepted a position on the board of directors of SOL Global Investments.